1. Oncofertility care in young women and the outcomes of pregnancy over the last 5 years
- Author
-
Junzo Hamanishi, Masumi Sunada, Sayuri Takahashi, Haruta Mogami, Akihito Horie, Akeo Kawamura, Masaki Mandai, Ayaka Yamaguchi, Hirohiko Tani, Eiji Kondoh, and Sachi Yamamura
- Subjects
cryopreservation of oocytes ,medicine.medical_specialty ,Pregnancy ,030219 obstetrics & reproductive medicine ,business.industry ,medicine.disease ,cryopreservation of ovarian tissues ,03 medical and health sciences ,oncofertility care ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Family medicine ,Female patient ,medicine ,cancer survivors ,business ,GnRH agonist ,Research Article ,Biotechnology ,Oncofertility - Abstract
Aim: To ascertain the actual outcomes of oncofertility care in young women to provide more appropriate care. Materials & methods: We analyzed the data of 67 female patients under 43 years of age who underwent oncofertility care between January 2015 and September 2019. Results: There were 28 patients with breast cancer, 19 patients with hematologic cancer and 20 patients with other cancer diagnoses. Breast cancer patients tended to take longer than hematologic cancer patients to initiate oncofertility treatment. Despite undergoing oncofertility care, seven of nine pregnant patients did not choose assisted reproductive technology (ART). Conclusion: As spontaneous pregnancies were more common than ART pregnancies in our study, pregnancy by not only ART but also non-ART method is a viable option for young cancer survivors., Lay abstract We conducted a study about oncofertility care and pregnancy outcomes in female cancer survivors under 43 years old. Even after chemotherapy, pregnancy by not only assisted reproductive technology (ART) but also non-ART method is a viable option for young cancer survivors. Social support as well as ART advancement is important for young cancer survivors and the low marriage rate may contribute to the low pregnancy rate.
- Published
- 2021
- Full Text
- View/download PDF